In a Drug Safety Update issued by the UK government on July 12, 2018, Dr. Dave Cardamone’s article titled “Eltrombopag and Serum of a Different Hue” is referenced as the lead publication that describes potential negative interference from eltrombopag on bilirubin testing and positive interference on creatinine test values. 

The Safety Update can be viewed here: https://www.gov.uk/drug-safety-update/eltrombopag-revolade-reports-of-interference-with-bilirubin-and-creatinine-test-results